Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “glp1 Agonist”

238 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 238 results

Early research (Phase 1)Study completedNCT00931372
What this trial is testing

Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 22
Testing effectiveness (Phase 2)Study completedNCT01832532
What this trial is testing

A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks

Who this might be right for
Sleep ApneaSleep Disordered Breathing
Children's Hospital Medical Center, Cincinnati 34
Post-approval studies (Phase 4)UnknownNCT02055014
What this trial is testing

Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)

Who this might be right for
Type 2 DiabetesObesityDiabesity
Sandwell & West Birmingham Hospitals NHS Trust 72
Post-approval studies (Phase 4)Looking for participantsNCT06754163
What this trial is testing

Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients

Who this might be right for
Obesity and Obesity-related Medical ConditionsPsychiatric Disorders
St Andrew's Healthcare 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07411378
What this trial is testing

Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.

Who this might be right for
Muscle WastingObesity & OverweightObesity
Biophytis 164
Not applicableStudy completedNCT05875636
What this trial is testing

GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy

Who this might be right for
Gastric Content Aspiration
Medical University of South Carolina 260
Not applicableLooking for participantsNCT07091500
What this trial is testing

Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity

Who this might be right for
ObesitySkeletal Muscle
Washington University School of Medicine 40
Large-scale testing (Phase 3)Study completedNCT00905255
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS)

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 69
Testing effectiveness (Phase 2)Study completedNCT05254418
What this trial is testing

Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease

Who this might be right for
Chronic Kidney Diseases
Vanderbilt University Medical Center 7
Post-approval studies (Phase 4)Study completedNCT02291874
What this trial is testing

Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Inc 100
Large-scale testing (Phase 3)Study completedNCT05205928
What this trial is testing

Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care

Who this might be right for
Type 1 DiabetesDiabetes Mellitus, Type 1
McGill University Health Centre/Research Institute of the McGill University Health Centre 28
Large-scale testing (Phase 3)Study completedNCT00715624
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 496
Post-approval studies (Phase 4)Looking for participantsNCT07136714
What this trial is testing

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity

Who this might be right for
Major Depressive Disorder
Nordsjaellands Hospital 116
Testing effectiveness (Phase 2)Looking for participantsNCT05254314
What this trial is testing

Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)

Who this might be right for
Asthma
Vanderbilt University Medical Center 100
Post-approval studies (Phase 4)Looking for participantsNCT07127354
What this trial is testing

The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality

Who this might be right for
GLP - 1Bowel Preparation for Colonoscopy
The Cleveland Clinic 132
Not applicableLooking for participantsNCT07224880
What this trial is testing

Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

Who this might be right for
glp1 AgonistGene ExpressionSkin Laxity
Cytrellis Biosystems, Inc. 10
Large-scale testing (Phase 3)Study completedNCT03954834
What this trial is testing

Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 478
Post-approval studies (Phase 4)UnknownNCT03018665
What this trial is testing

The Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese

Who this might be right for
Diabetes Mellitus, Type 2
The First Hospital of Jilin University 200
Not applicableStudy completedNCT07096739
What this trial is testing

Tolerance of a High Protein Nutrition Shake in Individuals on GLP-1

Who this might be right for
GLP-1 Concentration
Kate Farms Inc 20
Post-approval studies (Phase 4)Ended earlyNCT03029351
What this trial is testing

GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesKidney Diseases
University at Buffalo 15
Load More Results